Paloma Partners Management Co boosted its stake in Morgan Stanley (NYSE:MS) by 305.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 191,073 shares of the financial services provider’s stock after acquiring an additional 143,981 shares during the period. Paloma Partners Management Co’s holdings in Morgan Stanley were worth $8,371,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in MS. Eminence Capital LP acquired a new position in shares of Morgan Stanley during the second quarter worth approximately $141,913,000. Marshall Wace North America L.P. raised its position in shares of Morgan Stanley by 2,308.4% during the second quarter. Marshall Wace North America L.P. now owns 921,206 shares of the financial services provider’s stock worth $40,358,000 after purchasing an additional 882,957 shares during the period. Rock Creek Group LP acquired a new position in shares of Morgan Stanley during the second quarter worth approximately $1,314,000. Assetmark Inc. raised its position in shares of Morgan Stanley by 44.5% during the second quarter. Assetmark Inc. now owns 9,529 shares of the financial services provider’s stock worth $417,000 after purchasing an additional 2,936 shares during the period. Finally, Private Portfolio Partners LLC acquired a new position in shares of Morgan Stanley during the second quarter worth approximately $206,000. Institutional investors and hedge funds own 83.58% of the company’s stock.
A number of equities analysts have recently weighed in on the company. BMO Capital Markets set a $69.00 target price on Morgan Stanley and gave the stock a “buy” rating in a research report on Friday, July 19th. TheStreet lowered Morgan Stanley from a “b” rating to a “c+” rating in a research report on Wednesday, August 14th. Citigroup raised Morgan Stanley from a “neutral” rating to a “buy” rating and upped their target price for the stock from $48.00 to $52.00 in a research report on Friday, July 12th. Finally, Oppenheimer set a $65.00 target price on Morgan Stanley and gave the stock a “buy” rating in a research report on Friday, July 19th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the stock. Morgan Stanley has an average rating of “Hold” and a consensus target price of $56.45.
Morgan Stanley (NYSE:MS) last released its quarterly earnings results on Thursday, July 18th. The financial services provider reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.10. The business had revenue of $10.24 billion during the quarter, compared to analyst estimates of $10.02 billion. Morgan Stanley had a return on equity of 11.04% and a net margin of 16.06%. Morgan Stanley’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.30 EPS. On average, research analysts expect that Morgan Stanley will post 4.79 EPS for the current year.
Morgan Stanley Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments.
See Also: What is the definition of market timing?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.